Headquarter: Chemical Industry Park, Economic Development Zone,  JiNan City,  ShanDong Province, China.

Phone +86-152 8958 7728

Angela@BlueSkytcca.com

Heparin Calcium Market to Reach US$ 1700.8 Mn with a CAGR of … – Medgadget

February 6th, 2023 Releases
A form of anticoagulant is heparin calcium which is required to prevent and treat thrombotic actions like deep vein thrombosis (DVT), pulmonary embolism, and others. Unfractionated heparin and low molecular weight heparin (LMWH) are the two kinds of heparin calcium available. The former one is fast in behaving as a blood thinner which acts with antithrombin and helps in blood clotting. Unfractionated heparin does not discrete the clotting of blood. It helps in maturing and does not stop new formations, after the use of intravenous unfractionated heparin.
Globally, the market of heparin calcium is projected to be priced at US$ 1,370.9 Mn in the year 2022 and is anticipated to show a CAGR of 2.7% in the predicted period from 2022 to 2030.
Request Here For The Sample Copy Of The Report @ https://www.coherentmarketinsights.com/insight/request-sample/5483


Analysts’ Views on Global Market for Heparin Calcium:
The growth of the market of heparin calcium can be hampered by gaps in the treatment of atrial fibrillation. The most common anticoagulant is the heparin calcium used for deep vein thrombosis. For example, as per the data issued in February in NCBI (National Center for Biotechnology Information) is a cross-sectional and observational study conducted on 40 centers across Lebanon and Jordan. It started its operation that, of the total 704 patients, 366 patients used LMWH (low molecular weight heparin) for DVT (deep vein thrombosis). Thus, it can be claimed that LMWH is the most widely used anticoagulant.
Global Market for Heparin Calcium – Driver
The rising incidence of diseases like DVT (deep vein thrombosis) is anticipated to push the market of heparin calcium in the predicted period
The rising incidence of diseases like DVT (deep vein thrombosis) is anticipated to push the market of heparin calcium in the predicted period. As per data issued in the journal of BMC in October 2021, a study was carried out among 225 adults at Affiliated Hospital of Shangdong First Medical University in the year 2020 in identifying the incidence, factors of risk, and forecast of DVT (deep vein thrombosis). Thus, it was claimed that 40% patients had deep vein thrombosis owing to lower serum creatinine levels and lower partial pressure of arterial oxygen.
Global Market for Heparin Calcium- Regional Analysis
Amongst the region, Europe is projected to hold a dominating position in the market of heparin calcium in the predicted period. Europe held 40% share of the market owing to rising number of pulmonary embolism disease in the region. As per the data issued of thrombosis and hemostatis journal in October 2020, the incidence of pulmonary embolism in Europe was 23% in the review of systems in 2019.
Furthermore, as per the same source, the region of North America is anticipated to hold the second position in the market of heparin calcium in the predicted period. The incidence of pulmonary embolism in the region of North America was 8% in the review of system in 2019.
Global Market for Heparin Calcium – Impact of Coronavirus (COVID-19) Pandemic
Meanwhile the virus of COVID-19 and its outbreak in December 2019, the disease made its presence in about 100 countries worldwide and the WHO announced it as a public health emergency situation on 30th January 2020.
Covid-19 impacted the economy in three major ways by impacting directly the demand of drug and its manufacturing, by interrupting the supply and distribution network and then hampering the financial conditions of the financial markets and the firms. Owing to the lockdowns in many nations, various countries like Saudi Arabia, India, U.A.E., Egypt, China and others faced issues with transporting drugs from origin to destination.
Though, the pandemic of COVID-19 had successful effect on the market of heparin calcium. For example, as per data issued in American College of Cardiology’s Journal in May 2021, COVID-19 is related with a high prevalence of pulmonary embolism and DVT (deep vein thrombosis) from the clinical records of 1,000 patients with COVID-19. Thus, it was claimed that the cumulative prevalence/incidence of pulmonary embolism is 1.8% and that of DVT (deep vein thrombosis) were 2.5% in the year 2020. Therefore, successfully affecting the market growth of heparin calcium worldwide.
Global Market for Heparin Calcium Segmentation
Globally, the market report of heparin calcium is divided into type, application, route of administration, and distribution channel.
On the basis of type, the market is divided into unfractionated heparin and low molecular weight heparin (LMWH). Amongst which, the segment of LMWH is anticipated to control the position in the market of heparin calcium in the predicted period and this is credited owing to the rise in application of LMWH.
On the basis of route of administration, the market is divided into an intravenous and subcutaneous. Amongst which, the segment of intravenous is anticipated to control the market in the predicted period and this is credited owing to rise in the usage of intravenous for treating many diseases like DVT (deep vein thrombosis), pulmonary embolism and others.
On the basis of application, the market of heparin calcium is divided into DVT (Deep Vein Thrombosis), Kidney Dialysis, Pulmonary Embolism, Atrial Fibrillation, and Others (Cardiac Surgery, etc.). The segment of deep vein thrombosis is anticipated to control the market in the predicted period and this is credited to the rising incidence of deep vein thrombosis.
On the basis of distribution channel, the market of heparin calcium is divided into retail pharmacies, hospital pharmacies and online pharmacies. Amongst which, the segment of hospital pharmacies is anticipated to control the market in the predicted period and this is credited to the rise in number of such pharmacies.
Amongst all the segmentation, the segment of application has high potentiality owing to rising R&D (research and development) by the companies for treating DVT (deep vein thrombosis) treatment. For example, Sunnybrook Health Sciences Center in November 2021, in partnership with LEO Pharma A/S which is a pharmaceutical company, initiated a medical trial for treating DVT (deep vein thrombosis). This trial is anticipated to get completed in October 2023.
Direct Buy This Premium Research Report, Click Here @ https://www.coherentmarketinsights.com/insight/buy-now/5483
Global Market for Heparin Calcium Cross Sectional Analysis
In the segment of distribution channel, the segment of hospital pharmacies holds a dominating segment in the region of North America owing to the rising number of hospital pharmacies. For example, as per data given by the National Association of Pharmacy Regulatory Authorities in January 2022, the total number of pharmacies in Canada up till January 2022 was 11,814.
In the segment of application, deep vein thrombosis is dominating in the region of Asia Pacific owing to the rising number of product consent by the US FDA. For example, US FDA in May 2019 permitted Fragmin which is an anticoagulant for subcutaneous application in reducing the continuous symptomatic DVT (deep vein thrombosis) in pediatric patients of one month age or more.
Global Market for Heparin Calcium: Key Developments
The current R&D (research and development) by the main companies is anticipated to push the market of heparin calcium in the predicted period. For example, Galician Research Group on Digestive tumors in December 2022, in partnership with LEO Pharma A/S which is also a pharmaceutical initiated a medical trial to assess the efficiency of tinzaparin (low molecular weight heparin) in preventing of signs venous thromboembolic disease. The trial is anticipated to get completed in March 2025.
Rising use of inorganic strategies of growth like product consent by the controlling authorities like the US FDA is anticipated to push the growth of the market of heparin calcium in the predicted period. For example, Boehringer Ingelheim Pharmaceuticals Inc., is a pharmaceutical company in June 2021, declared that they had got a consent from the US Food and Drugs Administration for Dabigatran, which is an anticoagulant for children aging from three months to 11years of age in treating DVT (deep vein thrombosis).
Global Market for Heparin Calcium: Key Trends
The current R&D (research and development) on heparin calcium is anticipated to push the market of heparin calcium in the predicted period.
The current R&D on heparin calcium is anticipated to push the market of heparin calcium in the predicted period. For example, Anthos Therapeutics is a biopharmaceutical company on 27th September 2022 announced that they had initiated a medical trial on Dalteparin which is a low molecular weight heparin, for treating DVT (deep vein thrombosis).
Global Market for Heparin Calcium: Restraint
Several after effects related with the application of heparin calcium is anticipated to hamper the market of heparin calcium worldwide in the predicted period.
Several after effects related with the application of heparin calcium is anticipated to hamper the market the heparin calcium worldwide in the predicted period. For example, as per data issued in the journal of MDPI in August 2022, heparin is extensively used as an anticoagulant ingredient that augments the time of clotting. But, applying heparin is a threat owing to its life-threatening after effects like heparin-induced thrombocytopenia and thrombosis. Additionally, heparin is a tough electronegative and shows a bonding attraction for the helpful dynamic sites of human serum proteins, biochemical path activations, which adversely impacts dialysis patients.
Global Market for Heparin Calcium – Key Players
The main companies participating in the market of heparin calcium worldwide are Sanofi, Pfizer Inc., Dongying Tiandong Pharmaceutical Co., Ltd., PANPHARMA S.A., Merck KGaA, Teva Pharmaceutical Industries Ltd., SMITHFIELD BIOSCIENCE, Afine Chemicals Limited, Yino Pharma Limited, Shandong Sheelian Pharmaceutical Co., Ltd., Aspen Holdings, Opocrin S.p.A.
The Study Objectives are:
✔️ A comprehensive insight into key players operating in the Heparin Calcium Market and their corresponding data.
✔️ It includes product portfolio, annual revenue, expenditure on research and development, geographical presence, key developments in recent years, and growth strategies.
✔️ Regional analysis, which includes insight into the dominant market and corresponding market share.
✔️ It also includes various socio-economic factors affecting the evolution of the market in the region.
✔️ The report offers a comprehensive insight into different individuals from value chains such as raw materials suppliers, distributors, and stockholders.
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Heparin Calcium Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Heparin Calcium Industry Impact
Chapter 2 Global Heparin Calcium Competition by Types, Applications, and Top Regions and Countries
2.1 Global Heparin Calcium (Volume and Value) by Type
2.3 Global Heparin Calcium (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Heparin Calcium Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Heparin Calcium Market Analysis
Chapter 6 East Asia Heparin Calcium Market Analysis
Chapter 7 Europe Heparin Calcium Market Analysis
Chapter 8 South Asia Heparin Calcium Market Analysis
Chapter 9 Southeast Asia Heparin Calcium Market Analysis
Chapter 10 Middle East Heparin Calcium Market Analysis
Chapter 11 Africa Heparin Calcium Market Analysis
Chapter 12 Oceania Heparin Calcium Market Analysis
Chapter 13 South America Heparin Calcium Market Analysis
Chapter 14 Company Profiles and Key Figures in Heparin Calcium Business
Chapter 15 Global Heparin Calcium Market Forecast (2022-2028)
Chapter 16 Conclusions
Research Methodology
We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/5483
About US
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us
Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400,
Burlingame, CA 94010, United States
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
Sign up and submit a press release
Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

source

Leave a Reply

Your email address will not be published.

*